Abstract：Objective: To study the correlation between the gene polymorphism of cyclin dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) and endometriosis (EM). Methods: From December 2017 to July 2019, 112 patients with endometriosis admitted to Handan Central Hospital and the Fourth Hospital of Hebei Medical University were selected as the case group, and another 112 patients who were operated on due to ectopic pregnancy and tubal adhesion were selected as the control group. Detection of CDKN2B-AS1 gene polymorphism in blood of all subjects was made by DNA PCR sequencing, the relationship between rs10965235 polymorphism of CDKN2B-AS1 gene and clinical stage of EM was analyzed, and Logistic regression was used to analyze the effect of CDKN2B-AS1 gene polymorphism on EM susceptibility. Results: There was no significant difference in age, BMI, menstrual cycle, frequencies of allele A, G, AA, AG+GG at rs4977574 loci on CDKN2B-AS1 between the case group and the control group (P>0.05). Compared with the control group, the frequencies of alleles C and CC at rs10965235 on CDKN2B-AS1 gene in the case group were higher, and the frequencies of alleles A and CA+AA were lower (χ2=4.397, 4.075, P=0.036, 0.044) . Compared with AA genotype, GA + GG genotype at rs4977574 on CDKN2B-AS1 gene was not related to EM susceptibility (OR=1.105, 95% CI: 0.819~1.491; P=0.124). Compared with I ~ II phase, the frequency of CC genotype at rs10965235 on CDKN2B-AS1 gene in III ~ IV phase EM patients was higher, and the frequency of CA + AA genotype at rs10965235 loci on CDKN2B-AS1 gene was lower, and the differences were statistically significant (χ2=5.168, P=0.023). Compared with CC genotype, CA + AA genotype at rs10965235 on CDKN2B-AS1 gene could reduce EM susceptibility (OR=0.564, 95% CI: 0.347~0.917, P=0.000). Conclusions: The rs4977574 loci on CDKN2B-AS1 gene is not related to EM susceptibility, and the rs10965235 loci polymorphism is related to EM susceptibility of women in northern China.
郝娜, 贾亚静, 田芸婕, 路晓琳. CDKN2B-AS1基因多态性与子宫内膜异位症的相关性研究[J]. 河北医学, 2020, 26(6): 975-979.
HAO Na, et al. A Study on the Correlation Between CDKN2B-AS1 Gene Polymorphism and Endometriosis. HeBei Med, 2020, 26(6): 975-979.
[1] 赖曾珍,徐志红.TLR4受体基因多态性与子宫内膜异位症相关性探讨[J].标记免疫分析与临床,2017,24(6):631~634. [2] Han SJ, Lee JE, Cho YJ, et al. Genomic function of estrogen receptor beta in endometriosis[J]. Endocrinology, 2019,160(11):2495~2516. [3] 阳鑫妙,李雯雯,沈国松,等.42例自然流产组织的单核苷酸多态性微阵列芯片分析[J].中华医学遗传学杂志,2019,36(4):400~402. [4] 乔琳,文星艳,窦克非,等.CDKN2B-AS1基因多态性与女性早发冠心病的相关性研究[J].中国循环杂志,2017,32(12):1154~1157. [5] Fan YY, Chen HY, Chen W, et al. Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis[J]. Gynecol Endocrinol, 2018, 34(6):507~512. [6] Maged AM, Deeb WS, El Amir A, et al. Diagnostic accuracy of serum miR-122 and miR-199a in women with endometriosis[J]. Int Gynaecol Obstet, 2018,141(1):14~19. [7] Lu Y, Chen S, Wei L, et al. A Microfluidic-based SNP genotyping method for hereditary hearing-loss detection[J]. Anal Chem, 2019,91(9):6111~6117. [8] Wang XM, Ma ZY, Song N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis[J]. Eur Rev Med Pharmacol Sci, 2018,22(9):2513~2518. [9] 郑中华,季慧慧,陈楚嘉,等.健康人群CDKN2A和CDKN2B基因甲基化水平与衰老的相关性[J].南方医科大学学报,2019,39(6):724~730. [10] Kunnas T, Piesanen J, Nikkari ST. Association of a chromosome locus 9p21.3 CDKN2B-AS1 variant rs4977574 with hypertension: the TAMRISK study[J]. Genet Test Mol Biomarkers, 2018,22(5):327~330. [11] Lee GH, Choi YM, Hong MA, et al. Association of CDKN2B-AS and WNT4 genetic polymorphisms in Korean patients with endometriosis[J]. Fertil Steril, 2017,102(5):1393~1397.
2020, Vol. 26 
冀公网安备13080202000677号